The utilization of ultra-sensitive digital biomarker detection, including NfL and p-Tau, has rapidly grown and is emerging as an industry standard evidenced by the growing volume of publications and the magnitude of ongoing studies. However, improving the conclusions of these studies requires increasing the comparability of measurements of very low protein concentrations over extended periods. To achieve this goal, several key advances in reagent chemistry, quality, and manufacturing processes have been made, resulting in the launch of Quanterix’s new assay platform, Simoa® Advantage PLUS. During this live webinar, Wesley Straub, Ph.D., VP of Product Management, and Kishore Malyavantham, Ph.D., VP of Reagent Research and Development, will delve into the role of reagent design and manufacture. They will elucidate how these key elements directly influence their application within studies. Through the presentation of example data and case studies, attendees will gain insights into how Quanterix instruments synergize with Simoa® Advantage PLUS assays to optimize study outcomes and maximize the impact of ultra-sensitive biomarker detection in research settings.
Speakers
Wesley Straub, PhD, VP of Product Management
Kishore Malyavantham, PhD, VP of Reagent Research and Development
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…